What Should Specialty Pharmacists Know About the REVERCE Clinical Trial?

Article
Conference|Gastrointestinal Cancers Symposium

Kohei Shitara, MD, Department of Gastrointestinal Oncology of National Cancer Center Hospital East, Japan, discusses the importance of the REVERCE clinical trial for specialty pharmacists.

Related Videos
Young depressed woman talking to lady psychologist during session, mental health - Image credit: motortion | stock.adobe.com
Related Content
Peach ribbon for endometrial cancer awareness -- Image credit: Chinnapong | stock.adobe.com

FDA Accepts sBLA for Dostarlimab With Chemotherapy to Treat Endometrial Cancer

April 25th 2024
Article
Pharmacy Focus: Oncology Edition- Integrating Oncology Pharmacists into Multidisciplinary Care Teams for Improved Patient Outcomes

Pharmacy Focus: Oncology Edition- Integrating Oncology Pharmacists into Multidisciplinary Care Teams for Improved Patient Outcomes

March 26th 2024
Podcast
Stem cell transplant procedure -- Image credit: Vadim | stock.adobe.com

Advancement in Stem Cell Transplantation: Improving Outcomes for Patients With Blood Cancer

April 25th 2024
Article
Pharmacy Focus: Limited Series - Celebrity Endorsements in Pharmaceuticals

Pharmacy Focus: Limited Series - Celebrity Endorsements in Pharmaceuticals

February 28th 2024
Podcast
Artificial intelligence -- Image credit: Shuo | stock.adobe.com

Optimizing Oncological Care: The Influence of AI on Insurance Approvals

April 24th 2024
Article
FDA approval stamp -- Image credit: Olivier Le Moal | stock.adobe.com

FDA Approves Lutathera for Pediatric Patients With SSTR+ Gastroenteropancreatic Neuroendocrine Tumors

April 23rd 2024
Article
© 2024 MJH Life Sciences

All rights reserved.